About
Technology
Issues
FAQ
Links
Official Page
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.